Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-611
Closed -$127K 35
2018
Q3
$127K Sell
611
-632
-51% -$125K 0.04% 88
2018
Q2
$229K Buy
1,243
+46
+4% +$8.14K 0.09% 125
2018
Q1
$204K Sell
1,197
-300
-20% -$55.1K 0.09% 191
2017
Q4
$260K Buy
+1,497
New +$265K 0.11% 194

Other funds holding AMGN

C Partners Holding's AMGN Position: Q4 2018 in Review

C Partners Holding sold out of Amgen (AMGN) in Q4 2018, closing a stake of 611 shares — an estimated $127K sold.

C Partners Holding first reported a position in AMGN in Q4 2017 and held it in 4 quarters. The position peaked at $260K in Q4 2017. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • C Partners Holding reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
  • C Partners Holding sold 611 Amgen shares in Q4 2018, an estimated $127K.
  • C Partners Holding first reported a position in Amgen in Q4 2017 and held it in 4 quarters.
  • C Partners Holding's Amgen position peaked at $260K in Q4 2017.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.